Advertisement
Screener

Can-Fite BioPharma Ltd. (CANF) Form 6-K: Report of foreign private issuer, 2022

1.0 / 5 stars · 8/40 Roast Me

Add as a preferred source on Google

Can-Fite BioPharma Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2022-12-30: Form 6-K; Period of report 2022-12-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170981-6k_canfitebio.htm.
  • 2022-12-28: Form 6-K; Period of report 2022-12-28; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170927-6k_canfitebio.htm.
  • 2022-12-08: Form 6-K; Period of report 2022-12-08; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea169841-6k_canfitebio.htm.
  • 2022-11-25: Form 6-K; Period of report 2022-11-25; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea169276-6k_canfitebio.htm.
FiledFormPeriod of reportDescriptionDocument
2022-12-306-K2022-12-30REPORT OF FOREIGN PRIVATE ISSUERea170981-6k_canfitebio.htm
2022-12-286-K2022-12-28REPORT OF FOREIGN PRIVATE ISSUERea170927-6k_canfitebio.htm
2022-12-086-K2022-12-08REPORT OF FOREIGN PRIVATE ISSUERea169841-6k_canfitebio.htm
2022-11-256-K2022-11-25REPORT OF FOREIGN PRIVATE ISSUERea169276-6k_canfitebio.htm
2022-11-026-K2022-11-02REPORT OF FOREIGN PRIVATE ISSUERea167928-6k_canfitebio.htm
2022-10-256-K2022-10-25REPORT OF FOREIGN PRIVATE ISSUERea167507-6k_canfitebio.htm
2022-09-126-K2022-09-12REPORT OF FOREIGN PRIVATE ISSUERea165497-6k_canfite.htm
2022-09-076-K2022-09-07REPORT OF FOREIGN PRIVATE ISSUERea165455-6k_canfite.htm
2022-08-296-K2022-08-29REPORT OF FOREIGN PRIVATE ISSUERea165101-6k_canfite.htm
2022-08-256-K2022-06-30REPORT OF FOREIGN PRIVATE ISSUERea164764-6k_canfite.htm
2022-08-236-K2022-08-23REPORT OF FOREIGN PRIVATE ISSUERea164844-6k_canfite.htm
2022-08-226-K2022-08-22REPORT OF FOREIGN PRIVATE ISSUERea164761-6k_canfite.htm
2022-08-176-K2022-08-17REPORT OF FOREIGN PRIVATE ISSUERea164577-6k_canfite.htm
2022-07-256-K2022-07-25REPORT OF FOREIGN PRIVATE ISSUERea163210-6k_canfitebio.htm
2022-07-116-K2022-07-11REPORT OF FOREIGN PRIVATE ISSUERea162654-6k_canfitebio.htm
2022-06-296-K2022-06-29REPORT OF FOREIGN PRIVATE ISSUERea162236-6k_canfitebio.htm
2022-06-246-K2022-06-24REPORT OF FOREIGN PRIVATE ISSUERea162030-6k_canfitebio.htm
2022-06-096-K2022-06-09CURRENT REPORTea161339-6k_canfite.htm
2022-05-266-K2022-05-26REPORT OF FOREIGN PRIVATE ISSUERea160602-6k_canfitebio.htm
2022-05-166-K2022-05-16REPORT OF FOREIGN PRIVATE ISSUERea0159868-6k_canfitebio.htm
2022-05-026-K2022-05-02REPORT OF FOREIGN PRIVATE ISSUERea159177-6k_canfite.htm
2022-04-056-K2022-04-05CURRENT REPORT OF FOREIGN PRIVATE ISSUERea157995-6k_canfite.htm
2022-03-246-K2022-03-24REPORT OF FOREIGN PRIVATE ISSUERea157332-6k_canfite.htm
2022-03-146-K2022-03-14REPORT OF FOREIGN PRIVATE ISSUERea156801-6k_canfitebiopharma.htm
2022-03-116-K2022-03-11REPORT OF FOREIGN PRIVATE ISSUERea156718-6k_canfite.htm
2022-03-086-K2022-03-08FORM 6-Kea156559-6k_canfite.htm
2022-01-316-K2022-01-31REPORT OF FOREIGN PRIVATE ISSUERea154661-6k_canfite.htm
2022-01-136-K2022-01-13REPORT OF FOREIGN PRIVATE ISSUERea153962-6k_canfite.htm
2022-01-056-K2022-01-05FORM 6-Kea153473-6k_canfite.htm
Advertisement